News

Wegovy maker Novo Nordisk's sales hike in second quarter
Novo Nordisk on Wednesday posted second-quarter sales broadly in line with expectations, after last week cutting its ...
Wegovy maker Novo Nordisk to reduce costs after $95 billion stock loss
Wegovy-maker Novo Nordisk said on Wednesday it will sharpen its commercial focus and reduce costs, after a major profit ...
Mathrubhumi English6m
Ozempic maker Novo Nordisk sees 32 percent surge in Q2 net profit
Danish pharma giant Novo Nordisk reports 32% rise in Q2 net profit to $4.1B, driven by strong sales of Ozempic and Wegovy ...
Why Novo Nordisk Stock Is Down Again Today
Weston's downgrade still values Novo Nordisk stock above its current share price of $47 and change, however. Moreover, Novo ...
Novo Nordisk stock downgraded as Trump teases 250% pharma tariffs
President Donald Trump says pharma tariffs could go as high as 250%. UBS downgrades Novo Nordisk stock to neutral and lowers ...
Ozempic maker Novo Nordisk has its worst day since Black Monday
Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...
Watch These Novo Nordisk Stock Price Levels After Last Week's 33% Drop
Novo Nordisk's U.S.-listed shares shed a third of their value last week after the company cut its full-year outlook and named ...
The Manila Times38m
Novo Nordisk's sales increased by 16% in Danish kroner and by 18% at constant exchange rates to DKK 154.9 billion in the first six months of 2025
Financial report for the period 1 January 2025 to 30 June 2025                                                                                                                                          ...
Novo Nordisk to Disclose Full Second-Quarter Earnings Amid Management Reshuffle -- Earnings Preview
Novo Nordisk is scheduled to report results for the second quarter on Wednesday. Here is what you need to know: PROFIT FORECAST: The company pre-released preliminary second-quarter numbers last week, ...